Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women
Open Access
- 1 May 2007
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 88 (5), 1470-1478
- https://doi.org/10.1099/vir.0.82558-0
Abstract
Human papillomavirus (HPV) infection, particularly with types 16 and 18, is causally associated with the development of cervical cancer. Prophylactic vaccines against HPV have recently been licensed and have the primary aim of protecting children against future HPV infection and cervical cancer. However, these vaccines are unlikely to be effective in women with pre-existing HPV infection and disease. Previous studies have suggested that HPV16 E6-specific CD4+ T cells play a role in controlling viral infection; however, the epitopes recognized by such T-cells have not been defined. In this study, we analysed T-cell responses against HPV16 and 18 in ten healthy young women in an age group (21–31) with a high prevalence of HPV infection and clearance. Five individuals made HPV E6 responses, from which five candidate T-cell epitopes (three HPV16 E6 and two HPV18 E6) were identified. More detailed characterization of epitopes from HPV16 E6(127–141) and HPV18 E6(43–57) revealed HLA-DRB1*01 and HLA-DRB1*15 restriction, respectively. Furthermore, generation of a T-cell line against HPV16 E6(127–141) demonstrated that this epitope could be presented after endogenous processing of soluble HPV16 E6 protein. Overall we demonstrate a powerful approach for defining novel CD4+ T-cell epitopes from two oncogenic HPV types. This approach could be applied to study populations in developing countries with a high incidence of cervical cancer. Such epitopes could provide a more precise way of investigating the role of natural and vaccine-induced T-cell responses against HPV in blood and at sites of disease.Keywords
This publication has 27 references indexed in Scilit:
- E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class IInternational Journal of Cancer, 2004
- Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6Cancer Research, 2004
- Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening populationJournal of Clinical Pathology, 2004
- Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E6The Journal of Immunology, 2001
- EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in functionJCI Insight, 2001
- Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasiaInternational Journal of Cancer, 2000
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Immunological Events in Regressing Genital WartsAmerican Journal of Clinical Pathology, 1994
- Analysis of HLA‐DR expression on keratinocytes in cervical neoplasiaInternational Journal of Cancer, 1994
- Loss of MHC class‐I expression in cervical carcinomasInternational Journal of Cancer, 1990